The role of metabotropic glutamate receptors in Alzheimer's disease

被引:0
|
作者
Lee, H
Zhu, XW
O'Neill, MJ
Webber, K
Casadesus, G
Marlatt, M
Raina, AK
Perry, G
Smith, MA
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Eli Lilly & Co, Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England
关键词
Alzheimer's disease; glutamate receptor; selective neurodegeneration;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While glutamatergic transmission is severely altered by early degeneration of cortico-cortical connections and hippocampal projections in Alzheimer's disease (AD), the role of glutamate receptors in the pathogenesis of AD is not yet defined clearly. Nonetheless, as reviewed here, the topographical distribution of different types of receptors likely contributes to the regional selective nature of neuronal degeneration. In particular, metabotropic glutamate receptors (mGluR) may contribute the pathogenesis of many neurological conditions and also regulate neuronal vulnerability against cytotoxic stress. Thus, we here discuss the possible role of mGluR in the pathogenesis of AD based on the results from other neurodegenerative diseases that may give us clues to solve the mysterious selective neurodegeneration evident in AD.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 50 条
  • [31] Determining the Role of Metabotropic Glutamate Receptors in Glioma
    Nickols, H. H.
    Rook, J. M.
    Byun, N.
    Conn, P. J.
    [J]. CURRENT NEUROPHARMACOLOGY, 2011, 9 : 46 - 47
  • [32] ROLE OF METABOTROPIC GLUTAMATE RECEPTORS (MGLURS) IN EPILEPTOGENESIS
    BEACH, RL
    THIEDE, BA
    XIONG, XY
    MEEKER, RB
    GREENWOOD, RS
    [J]. EPILEPSIA, 1995, 36 : 230 - 230
  • [33] Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease
    P. Bonsi
    D. Cuomo
    B. Picconi
    G. Sciamanna
    A. Tscherter
    M. Tolu
    G. Bernardi
    P. Calabresi
    A. Pisani
    [J]. Amino Acids, 2007, 32 : 189 - 195
  • [34] Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease
    Bonsi, P.
    Cuomo, D.
    Picconi, B.
    Sciamanna, G.
    Tscherter, A.
    Tolu, M.
    Bernardi, G.
    Calabresi, P.
    Pisani, A.
    [J]. AMINO ACIDS, 2007, 32 (02) : 189 - 195
  • [35] Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
    Niswender, Colleen M.
    Conn, P. Jeffrey
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 : 295 - 322
  • [37] Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease
    Dickerson, Jonathan W.
    Conn, P. Jeffrey
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (02) : 221 - 232
  • [38] Differential regulation of glutamate receptors in Alzheimer's disease
    Lee, HG
    Zhu, XW
    Ghanbari, HA
    Ogawa, O
    Raina, AK
    O'Neill, MJ
    Perry, G
    Smith, MA
    [J]. NEUROSIGNALS, 2002, 11 (05) : 282 - 292
  • [39] Glutamate Receptors in Alzheimer's Disease: Mechanisms and Therapies
    Anggono, Victor
    Tsai, Li-Huei
    Goetz, Juergen
    [J]. NEURAL PLASTICITY, 2016, 2016
  • [40] The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: Implications for the therapy of Parkinson's disease
    Wardas, J
    Pietraszek, M
    Wolfarth, S
    Ossowska, K
    [J]. NEUROSCIENCE, 2003, 122 (03) : 747 - 756